Coronary Artery Diseases (CAD) is one of the most prevalent causative agents of morbidity and mortality, worldwide [1]. Many
studies have been reported the role of statins that not only reduce risk of myocardial infarction, stroke and mortality in high risk
individuals but also improve clinical outcomes among patients undergoing Percutaneous Coronary Intervention